BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 30082909)

  • 1. Immunoregulatory protein B7-H3 regulates cancer stem cell enrichment and drug resistance through MVP-mediated MEK activation.
    Liu Z; Zhang W; Phillips JB; Arora R; McClellan S; Li J; Kim JH; Sobol RW; Tan M
    Oncogene; 2019 Jan; 38(1):88-102. PubMed ID: 30082909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B7 homolog 3 induces lung metastasis of breast cancer through Raf/MEK/ERK axis.
    Wang S; Zhang X; Ning H; Dong S; Wang G; Sun R
    Breast Cancer Res Treat; 2022 Jun; 193(2):405-416. PubMed ID: 35312883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer.
    Cho Y; Lee HW; Kang HG; Kim HY; Kim SJ; Chun KH
    Oncotarget; 2015 Apr; 6(11):8709-21. PubMed ID: 25909162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation.
    Liu H; Tekle C; Chen YW; Kristian A; Zhao Y; Zhou M; Liu Z; Ding Y; Wang B; Mælandsmo GM; Nesland JM; Fodstad O; Tan M
    Mol Cancer Ther; 2011 Jun; 10(6):960-71. PubMed ID: 21518725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The co-stimulatory molecule B7-H3 promotes the epithelial-mesenchymal transition in colorectal cancer.
    Jiang B; Zhang T; Liu F; Sun Z; Shi H; Hua D; Yang C
    Oncotarget; 2016 May; 7(22):31755-71. PubMed ID: 27145365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3.
    Zhang T; Jiang B; Zou ST; Liu F; Hua D
    World J Gastroenterol; 2015 Feb; 21(6):1804-13. PubMed ID: 25684945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B7-H3 overexpression in pancreatic cancer promotes tumor progression.
    Zhao X; Li DC; Zhu XG; Gan WJ; Li Z; Xiong F; Zhang ZX; Zhang GB; Zhang XG; Zhao H
    Int J Mol Med; 2013 Feb; 31(2):283-91. PubMed ID: 23242015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of B7-H3 reverses oxaliplatin resistance in human colorectal cancer cells.
    Zhang P; Chen Z; Ning K; Jin J; Han X
    Biochem Biophys Res Commun; 2017 Aug; 490(3):1132-1138. PubMed ID: 28676400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.
    Gysin S; Lee SH; Dean NM; McMahon M
    Cancer Res; 2005 Jun; 65(11):4870-80. PubMed ID: 15930308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1α.
    Lim S; Liu H; Madeira da Silva L; Arora R; Liu Z; Phillips JB; Schmitt DC; Vu T; McClellan S; Lin Y; Lin W; Piazza GA; Fodstad O; Tan M
    Cancer Res; 2016 Apr; 76(8):2231-42. PubMed ID: 27197253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B7-H3 regulates KIF15-activated ERK1/2 pathway and contributes to radioresistance in colorectal cancer.
    Ma Y; Zhan S; Lu H; Wang R; Xu Y; Zhang G; Cao L; Shi T; Zhang X; Chen W
    Cell Death Dis; 2020 Oct; 11(10):824. PubMed ID: 33011740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
    Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
    Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-199a Inhibits Cell Proliferation, Migration, and Invasion and Activates AKT/mTOR Signaling Pathway by Targeting B7-H3 in Cervical Cancer.
    Yang X; Feng KX; Li H; Wang L; Xia H
    Technol Cancer Res Treat; 2020; 19():1533033820942245. PubMed ID: 32856542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2.
    Shi T; Ma Y; Cao L; Zhan S; Xu Y; Fu F; Liu C; Zhang G; Wang Z; Wang R; Lu H; Lu B; Chen W; Zhang X
    Cell Death Dis; 2019 Apr; 10(4):308. PubMed ID: 30952834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes.
    Tekle C; Nygren MK; Chen YW; Dybsjord I; Nesland JM; Maelandsmo GM; Fodstad O
    Int J Cancer; 2012 May; 130(10):2282-90. PubMed ID: 21671471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The requirement of SEPT2 and SEPT7 for migration and invasion in human breast cancer via MEK/ERK activation.
    Zhang N; Liu L; Fan N; Zhang Q; Wang W; Zheng M; Ma L; Li Y; Shi L
    Oncotarget; 2016 Sep; 7(38):61587-61600. PubMed ID: 27557506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7-H3 promotes multiple myeloma cell survival and proliferation by ROS-dependent activation of Src/STAT3 and c-Cbl-mediated degradation of SOCS3.
    Lin L; Cao L; Liu Y; Wang K; Zhang X; Qin X; Zhao D; Hao J; Chang Y; Huang X; Liu B; Zhang J; Lu J; Ge Q
    Leukemia; 2019 Jun; 33(6):1475-1486. PubMed ID: 30573782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of B7-H3 reduces the glycolytic capacity and sensitizes breast cancer cells to AKT/mTOR inhibitors.
    Nunes-Xavier CE; Karlsen KF; Tekle C; Pedersen C; Øyjord T; Hongisto V; Nesland JM; Tan M; Sahlberg KK; Fodstad Ø
    Oncotarget; 2016 Feb; 7(6):6891-901. PubMed ID: 26771843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.